Edit |   |
---|---|
Product Name | REmAb® de novo Antibody Sequencing by Mass Spectrometry |
Description | The REmAb® de novo antibody sequencing workflow delivers the complete antibody sequence, including CDRs, with unparalleled accuracy and reliability. Starting with just 100µg of purified antibody, the sample undergoes multi-enzyme digestions and the fragments are measured with LC-MS/MS to derive the de novo peptide sequences. These fragments are then analyzed by Rapid Novor's suite of bioinformatics algorithms to assemble the full-length antibody sequences of any isotype. Our unique de novo workflow allows us to determine the full antibody sequence with hundreds of overlapped peptides without requiring a database or sequence library for reference or homology. |
Size | n/a |
Concentration | n/a |
Applications | n/a |
Other Names | n/a |
Gene, Accession, CAS # | n/a |
Catalog # | n/a |
Price | please inquire |
Order / More Info | REmAb® de novo Antibody Sequencing by Mass Spectrometry from RAPID NOVOR INC. |
Product Specific References | n/a |
Europe
Johan Enschedeweg 13
Uithoorn, 1422 DR
The Netherlands
U.S.A.
135 Beaver Street, Suite 204
Waltham, MA 02452